Carbamazepin 200 mg/1 (Carbamazepine TABLET, EXTENDED RELEASE) 200 mg/1

Carbamazepine 200 mg extended-release tablets are an anticonvulsant medication used to manage certain types of seizures and nerve pain. This extended-release formulation is designed to provide steady drug levels in the body.

Strength

200 mg/1

Pack Size

100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0832-6023-11)

Manufacturer / TM Owner

Upsher-Smith Laboratories, LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Carbamazepine is primarily used to control seizures in conditions like epilepsy. It is also prescribed for nerve pain, such as trigeminal neuralgia. The extended-release tablets help maintain consistent medication levels, which may reduce the frequency of dosing. Carbamazepine works by stabilizing electrical activity in the brain and affecting how nerves send pain signals.

Side Effects

Common effects of Carbamazepine may include dizziness, drowsiness, and blurred vision. Some users might experience nausea or vomiting. These effects can vary and may not affect everyone. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

Carbamazepine should be handled with care, especially for those with a history of liver or kidney issues. It is important to follow the prescribed dosage and not to stop taking the medication abruptly. Extended-release tablets should be swallowed whole, not crushed or chewed.

Avoid Interactions

Carbamazepine can interact with various medications, including other anticonvulsants, antidepressants, and certain antibiotics. It is important to inform your healthcare provider about all medications you are taking. Alcohol and other central nervous system depressants may also interact with Carbamazepine.

Frequently Asked Questions

Carbamazepine is used to manage certain types of seizures and nerve pain, such as trigeminal neuralgia.

Extended-release tablets should be swallowed whole with water, typically once or twice daily as prescribed.

Common side effects may include dizziness, drowsiness, nausea, and blurred vision.

It is generally advised to avoid alcohol while taking Carbamazepine, as it may increase the risk of side effects.

If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.